Nicotine medications for smoking cessation

New England Journal of Medicine

Volumn 333, Issue 18, 1995, Pages 1196-1203

  Wood, Alastair J j ^a   Henningfield, Jack E ^b  

^a Johns Hopkins University School of Medicine ^*

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM;

CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; DEPENDENT PERSONALITY DISORDER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADOLESCENT; DRUG INTERACTIONS; HUMAN; NICOTINE; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS;

EID: 0028849333     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199511023331807     Document Type: Review

References (101)

1. Henningfield JE, Cohen C, Slade JD Is nicotine more addictive than cocaine? Br J Addict 1991; 86: 565-569
2. Hughes JR, Gulliver SB, Fenwick JW, Smoking cessation among self-quitters. Health Psychol 1992; 11: 331-334
3. Fiore MC Trends in cigarette smoking in the United States: the epidemiology of tobacco use. Med Clin North Am 1992; 76: 289-303
4. Department of Health and Human Services. The health consequences of smoking: nicotine addiction: a report of the Surgeon General, 1988. Washington, D.C.: Government Printing Office, 1988. (DHHS publication no. (CDC) 88-8406.)
5. Department of Health and Human Services. Preventing tobacco use among young people: a report of the Surgeon General, 1994. Washington, D.C.: Government Printing Office, 1994.
6. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from smoking in developed countries 1950– 2000: indirect estimates from national vital statistics. Oxford, England: Oxford University Press, 1994.
7. Henningfield JE, Schuh LM, Jarvik ME. Pathophysiology of tobacco dependence. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995.
8. Hughes JR, Higgins ST, Hatsukami D. Effects of abstinence from tobacco. In: Kozlowski LT, Annis HM, Cappell HD, et al., eds. Research advances in alcohol and drug problems. New York: Plenum Press, 1990:317-98.
9. Kottke TE, Brekke ML, Solberg LI, Hughes JR A randomized trial to increase smoking intervention by physicians: doctors helping smokers, round 1. JAMA 1989; 261: 2101-2106
10. Hughes JR Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies, and suggestions for future research. J Consult Clin Psychol 1993; 61: 751-760
11. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
12. Lide DR, ed. CRC handbook of chemistry and physics: 1991– 1992. 72nd ed. Boca Raton, Fla.: CRC Press, 1991.
13. Armitage AK, Turner DM Absorption of nicotine in cigarette and cigar smoke through the oral mucosa. Nature 1970; 226: 1231-1232
14. Henningfield JE, Radzius A, Cone EJ Estimation of available nicotine content of six smokeless tobacco products. Tob Control 1995; 4: 57-61
15. Gori GB, Benowitz NL, Lynch CJ Mouth versus deep airways absorption of nicotine in cigarette smokers. Pharmacol Biochem Behav 1986; 25: 1181-1184
16. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 1993; 33: 23-29
17. Benowitz NL, Porchet H, Sheiner L, Jacob P III Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988; 44: 23-28
18. Benowitz NL Nicotine replacement therapy: what has been accomplished -- can we do better? Drugs 1993; 45: 157-170
19. Johansson CJ, Olsson P, Bende M, Carlsson T, Gunnarsson PO Absolute bioavailability of nicotine applied to different nasal regions. Eur J Clin Pharmacol 1991; 41: 585-588
20. Benowitz NL, Henningfield JE Establishing a nicotine threshold for addiction: the implications for tobacco regulation. N Engl J Med 1994; 331: 123-125
21. Henningfield JE, Kozlowski LT, Benowitz NL A proposal to develop meaningful labeling for cigarettes. JAMA 1994; 272: 312-314
22. Benowitz NL, Jacob P III, Denaro C, Jenkins R Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 1991; 49: 270-277
23. Benowitz NL, Hall SM, Herning RI, Jacob P III, Jones RT, Osman A-L Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 1983; 309: 139-142
24. Palmer KJ, Buckley MM, Faulds D Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44: 498-527
25. Gorsline J Nicotine pharmacokinetics of four nicotine transdermal systems. Health Values 1993; 17: 20-24
26. Fagerstrom KO, Sawe U, Tonnesen P Therapeutic use of nicotine patches: efficacy and safety. J Drug Dev 1993; 5: 191-205
27. Russell MAH The future of nicotine replacement. Br J Addict 1991; 86: 653-658
28. Henningfield JE, Keenan RM Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 1993; 61: 743-750
29. Henningfield JE, Radzius A, Cooper TM, Clayton RR Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA 1990; 264: 1560-1564
30. Ross HD, Chan KK, Piraino AJ, John VA Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers. Pharm Res 1991; 8: 385-388
31. Gorsline J, Okerholm RA, Rolf CN, Moos CD, Hwang SS Comparison of plasma nicotine concentrations after application of nicoderm (nicotine transdermal system) to different skin sites. J Clin Pharmacol 1992; 32: 576-581
32. Dubois JP, Sioufi A, Muller P, Mauli D, Imhof PR Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems. Methods Find Exp Clin Pharmacol 1989; 11: 187-195
33. Sutherland G, Stapleton JA, Russell MAH, Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340: 324-329
34. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993; 269: 1268-1271
35. Malcolm RE, Sillett RW, Turner JA, Ball KP The use of nicotine chewing gum as an aid to stopping smoking. Psychopharmacology 1980; 70: 295-296
36. Hjalmarson AIM Effect of nicotine chewing gum in smoking cessation: a randomized, placebo-controlled, double-blind study. JAMA 1984; 252: 2835-2838
37. Silagy C, Mant D, Fowler G, Lokge M Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-142
38. Fiore MC, Smith SS, Jorenby DE, Baker TB The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271: 1940-1947
39. Hall SM, Tunstall C, Rugg D, Jones RT, Benowitz N Nicotine gum and behavioral treatment in smoking cessation. J Consult Clin Psychol 1985; 53: 256-258
40. Jarvis MJ, Raw M, Russell MAH, Feyerabend C Randomised controlled trial of nicotine chewing gum. BMJ 1982; 285: 537-540
41. Sachs DPL, Sawe U, Leischow SJ Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993; 153: 1881-1890 [Erratum, Arch Intern Med 1993;153:2321.]
42. Hurt RD, Dale LC, Offord KP, Bruce BK, McClain FL, Eberman KM Inpatient treatment of severe nicotine dependence. Mayo Clin Proc 1992; 67: 823-828
43. Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliott ML, Schweiger A Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 1983; 8: 253-261
44. The Research Committee of the British Thoracic Society. Comparison of four methods of smoking withdrawal in patients with smoking-related diseases. BMJ 1983; 286: 595-597
45. Fiore MC, Jorenby DE, Baker TB, Kenford SL Tobacco dependence and the nicotine patch: clinical guidelines for effective use. JAMA 1992; 268: 2687-2694
46. Russell MAH, Stapleton JA, Feyerabend C, Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 1993; 306: 1308-1312
47. Tonnesen P, Norregaard J, Simonsen K, Sawe U A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-315
48. Tonnesen, P, Norregaard J, Sawe U Two-year outcome in a smoking cessation trial with a nicotine patch. J Smok Relat Disord 1992; 3: 241-245
49. Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healey ML Nicotine vs. placebo gum in general medical practice. JAMA 1989; 261: 1300-1305
50. Tonnesen P, Fryd V, Hansen M, Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988; 318: 15-18
51. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials. JAMA 1991; 266: 3133-3138
52. Pickworth WB, Herning RI, Henningfield JE Spontaneous EEg changes during tobacco abstinence and nicotine substitution in human volunteers. J Pharmacol Exp Ther 1989; 251: 976-982
53. Snyder FR, Davis FC, Henningfield JE The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. Drug Alcohol Depend 1989; 23: 259-266
54. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995; 333: 1165-1170
55. Department of Health and Human Services. The health benefits of smoking cessation: a report of the Surgeon General, 1990. Washington, D.C.: Government Printing Office, 1990. (DHHS publication no. (CDC) 90-8416.)
56. Hall SM, Tunstall CD, Vila KL, Duffy J Weight gain prevention and smoking cessation: cautionary findings. Am J Public Health 1992; 82: 799-803
57. Gross J, Stitzer ML Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology 1989; 98: 334-341
58. Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR Nicotine gum: dose-related effects on cigarette smoking and subjective ratings. Psychopharmacology 1987; 92: 424-430
59. Jasinski DR, Henningfield JE Conceptual basis of replacement therapies for chemical dependence. Prog Clin Biol Res 1988; 261: 13-34
60. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB Predicting smoking cessation: who will quit with and without the nicotine patch? JAMA 1994; 271: 589-594
61. Jarvik ME, Henningfield JE. Pharmacological adjuncts for the treatment of nicotine dependence. In: Orleans CT, Slade J, eds. Nicotine addiction: principles and management. New York: Oxford University Press, 1993:245-61.
62. Jasinski DR. Chemical dependence. In: Harvey AM, Johns RJ, McKusick VA, Owens AH Jr, Ross RS, eds. The principles and practices of medicine. 22nd ed. Norwalk, Conn.: Appleton & Lange, 1988:1144-8.
63. Newhouse PA, Hughes JR The role of nicotine and nicotine mechanisms in neuropsychiatric disease. Br J Addict 1991; 86: 521-526
64. Hughes JR Nicotine gum to treat panic attacks? Am J Psychiatry 1986; 143: 271-271
65. Fagerstrom KO, Pomerleau O, Giordant B, Stelson F Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 1994; 116: 117-119
66. Gothe B, Strohl KP, Levin S, Cherniack NS Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 1985; 87: 11-17
67. Srivastava ED, Russell MAH, Feyerabend C, Williams GT, Masterson JG, Rhodes J Transdermal nicotine in active ulcerative colitis. Eur J Gastroenterol Hepatol 1991; 3: 815-818
68. Henningfield JE, Singleton EG Managing drug dependence: psychotherapy or pharmacotherapy? CNS Drugs 1994; 1: 317-322
69. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO The FagerstrãƒÂ¶m test for nicotine dependence: a revision of the FagerstrãƒÂ¶m Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127
70. Hughes JR An algorithm for smoking cessation. Arch Fam Med 1994; 3: 280-285
71. Sachs DPL. Effectiveness of 4 mg nicotine polacrilex for the initial treatment of high-dependent smokers. Arch Intern Med (in press).
72. Killen JD, Fortmann SP, Newman B, Varady A Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990; 58: 85-92
73. Dale LC, Hurt RD, Offord KP, et al. High dose nicotine patch therapy. JAMA (in press).
74. Kozak J, Fagerstrom KO, Sawe U High-dose treatment with the nicotine patch. Int J Smok Cessation 1995; 4: 26-28
75. Shiffman S Tobacco “chippersã¢â‚¬Â -- individual differences in tobacco dependence. Psychopharmacology 1989; 97: 539-547
76. Fagerstrom KO, Schneider NG, Lunell E Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology 1993; 111: 271-277
77. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24: 41-47
78. Hughes JR Risk-benefit assessment of nicotine preparations in smoking cessation. Drug Saf 1993; 8: 49-56
79. Division of Drugs and Toxicology. Drug evaluations: annual 1994. Chicago: American Medical Association, 1994.
80. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993; 306: 1304-1308
81. Fagerstrom KO, Lunell E, Molander L Continuous and intermittent transdermal delivery of nicotine: blockade of withdrawal symptoms and side effects. J Smok Relat Disord 1991; 2: 173-180
82. Hughes JR, Gust SW, Keenan R, Fenwick JW, Skoog K, Higgins ST Long-term use of nicotine vs. placebo gum. Arch Intern Med 1991; 151: 1993-1998
83. Waranch HR, Henningfield JE, Edmunds M Elimination of nicotine gum use following successful replacement therapy for cigarette smoking. Lancet 1988; 1: 49-50
84. Hurt RD, Offord KP, Lauger GG, Cessation of long-term nicotine gum use -- a prospective, randomized trial. Addiction 1995; 90: 407-413
85. Burling TA, Bigelow GE, Robinson JC, Mead AM Smoking during pregnancy: reduction via objective assessment and directive advice. Behav Ther 1991; 22: 31-40
86. Benowitz NL Nicotine replacement therapy during pregnancy. JAMA 1991; 266: 3174-3177
87. Benowitz NL Nicotine and coronary heart disease. Trends Cardiovasc Med 1991; 1: 315-321
88. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine-replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989-995
89. Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users -- United States, 1993. MMWR Morb Mortal Wkly Rep 1994; 43: 745-750
90. Lynch BS, Bonnie RJ, eds. Growing up tobacco free: preventing nicotine addiction in children and youths. Washington, D.C.: National Academy Press, 1994.
91. Breslau N, Kilbey MM, Andreski P Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149: 464-469
92. Glassman AH Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993; 150: 546-553
93. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993; 50: 36-43
94. Hughes JR Treatment of smoking cessation in smokers with past alcohol/drug problems. J Subst Abuse Treat 1993; 10: 181-187
95. Hartman N, Jarvik ME, Wilkins JN Reduction of cigarette smoking by use of a nicotine patch. Arch Gen Psychiatry 1989; 46: 289-289
96. Lee BL, Benowitz NL, Jacob P III Cigarette abstinence, nicotine gum, and theophylline disposition. Ann Intern Med 1987; 106: 553-555
97. Kozlowski LT, Henningfield JE, Keenan RM, Patterns of alcohol, cigarette, and caffeine and other drug use in two drug abusing populations. J Subst Abuse Treat 1993; 10: 171-179
98. Benowitz NL, Hall SM, Modin G Persistent increase in caffeine concentrations in people who stop smoking. BMJ 1989; 298: 1075-1076
99. Sachs D, Benowitz N. The nicotine withdrawal syndrome: nicotine absence or caffeine excess? In: Harris LS, ed. Problems of drug dependence 1988: proceedings of the 50th Annual Scientific Meeting: the Committee on Problems of Drug Dependence, Inc. NIDA research monograph 90. Washington, D.C.: Government Printing Office, 1988:38. (DHHS publication no. (ADM) 89-1605.)
100. Henningfield JE. Introduction to harm reduction as a complementary strategy to smoking cessation. tob Control (in press).
101. Henningfield JE, Ramstrom LM, Husten CG, Smoking and the workplace: realities and solutions. J Smok Relat Disord 1994; 5: Suppl 1: 261-270